Source: International Journal of Ophthalmology. Unidade: FMRP
Subjects: DIABETES MELLITUS, EDEMA MACULAR CISTOIDE, TOMOGRAFIA, DOENÇAS RETINIANAS
ABNT
WILLMANN, Gabriel et al. Foveal thickeness reduction after anti-vascular endothelial growth factor treatment in chronic diabetic macular edema. International Journal of Ophthalmology, v. 10, n. 5, p. 760-764, 2017Tradução . . Disponível em: https://doi.org/10.18240/ijo.2017.05.17. Acesso em: 23 ago. 2024.APA
Willmann, G., Nepomuceno, A. B., Messias, K., Barroso, L., Scott, I. U., Messias, A. M. V., & Jorge, R. (2017). Foveal thickeness reduction after anti-vascular endothelial growth factor treatment in chronic diabetic macular edema. International Journal of Ophthalmology, 10( 5), 760-764. doi:10.18240/ijo.2017.05.17NLM
Willmann G, Nepomuceno AB, Messias K, Barroso L, Scott IU, Messias AMV, Jorge R. Foveal thickeness reduction after anti-vascular endothelial growth factor treatment in chronic diabetic macular edema [Internet]. International Journal of Ophthalmology. 2017 ; 10( 5): 760-764.[citado 2024 ago. 23 ] Available from: https://doi.org/10.18240/ijo.2017.05.17Vancouver
Willmann G, Nepomuceno AB, Messias K, Barroso L, Scott IU, Messias AMV, Jorge R. Foveal thickeness reduction after anti-vascular endothelial growth factor treatment in chronic diabetic macular edema [Internet]. International Journal of Ophthalmology. 2017 ; 10( 5): 760-764.[citado 2024 ago. 23 ] Available from: https://doi.org/10.18240/ijo.2017.05.17